Substituted annellated pyrimidines and use thereof

US8859569B2 · kind B2 · utility

Assignees

• Bayer Pharma Aktiengesellschaft · DE
• Bayer Intellectual Property GmbH · DE

Inventors

• Markus Follmann
• Johannes-Peter Stasch · Wuppertal, DE
• Gorden Redlich · Bochum, DE
• Nils Griebenow · Milford, US
• Dieter Lang · Velbert, DE
• Frank Wunder · Wuppertal, DE
• Walter Hubsch · Wuppertal, DE
• Niels Lindner · Wuppertal, DE
• Alexandros Vakalopoulos · Hilden, DE
• Adrian Tersteegen · Wuppertal, DE

Key dates

• Filing date: Aug 30, 2012
• Grant date: Oct 14, 2014
• Expiry date: Aug 30, 2032

Classification

• Technology area (CPC C): Chemistry; Metallurgy
• CPC primary: C07D519/00
• WIPO field: Pharmaceuticals
• WIPO sector: Chemistry

Abstract

The present application relates to novel substituted annellated pyrimidines, methods for production thereof, use thereof alone or in combinations for treating and/or preventing diseases and use thereof for the production of medicinal products for treating and/or preventing diseases, in particular for treating and/or preventing cardiovascular diseases.